2Quieshi AI, Suri MF, Kirmani JF, et al. Prevalence and trends of prehy- pertension and hypertension in United States:National Health and Nutri- tion Examination Surveys 1976 to 2000. Med Sci Monit, 2005, 11: CR403-409.
3Ramos E ,Barros H. Pervalence of hypertension in 13-year-old dolescents in Potro, Portugal. Rev Port Cardiol,2005,24:1075-1087.
4Wang Y, Wang QJ, The prevalenee of prehypertension and hypertensionamong US adults according to the new Joint National Committee uide- lines. Areh Intern Med,2004,164:2126-2134.
6Vasan RS, Larson MG, Leip EP, et al. Assessment of frequency of pro- gression to hypertension in non-hypertensive participants in the Framing- ham Heart Study:a cohort study. Lancet,2001,358:1682-1686.
7Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for eveloping hypertension in middle-aged women and men:The Framingham Heart Study. JAMA ,2002,287 : 1003-1010.
8Crysohoou C, Pitsavos C, Panagiotakos DB, et al. Association between prehypertension status and inflammatory markers related to athero sclerot- ic disease : the AIq'ICA study. Am J Hypertens ,2004,17:568-573.
9Gao Y,Zeng Z,Li T,et al.Polydatin inhibits mitochondrial dysfunction in the renal tubular epithelial cells of a rat model of sepsis-induced acute kidney injury[J].Anesth Analg,2015,121(5):1 251.
10Chevalier RL,Forbes MS,Thornhill BA.Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy[J].Kidney Int,2009,75(11):1 145.
